Balloon Kyphoplasty Devices Market
Balloon Kyphoplasty Devices Market Size, Share & Industry Analysis, By Product Type (Balloon Catheters, Bone Cement, Needles, Inflatable Bone Tamps), By Application (Osteoporotic Fractures, Traumatic Fractures, Multiple Myeloma), By End User (Hospitals, Ambulatory Surgical Centres, Speciality Clinics), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa): Share, Size, Outlook, and Opportunity Analysis, 2024-2031.
Market Overview:
“The balloon Kyphoplasty devices market is expected to develop at a 5.8% CAGR from 2024 to 2031. The market value is predicted to rise from XX USD in 2024 to YY USD in 2031, with North America emerging as the leading area.”
Key metrics include the increased prevalence of osteoporosis, the growing senior population, and technological breakthroughs in minimally invasive spine procedures. The growing demand for effective treatment options for spinal compression fractures, as well as the increasing acceptance of minimally invasive spine surgery treatments, are driving market expansion.
Balloon Kyphoplasty Devices Market Dynamics:
Market Trend: Shift towards outpatient procedures driving market growth
The balloon kyphoplasty device industry is experiencing a considerable shift towards outpatient operations. This trend is mostly the result of advances in surgical methods, enhanced anesthesia regimes, and a growing demand for minimally invasive surgeries. Outpatient kyphoplasty operations provide numerous benefits, including shorter hospital stays, lower healthcare expenses, and faster recovery times.
Healthcare providers are increasingly using these techniques to improve patient outcomes and maximize resource utilization. The increased emphasis on value-based treatment, as well as the need to cut healthcare spending, are further driving this trend. As a result, manufacturers are designing devices expressly for outpatient settings, which will help to expand the market and increase the acceptance of balloon kyphoplasty treatments.
Market Driver: Rising prevalence of osteoporosis and vertebral compression fractures
The rising incidence of osteoporosis and accompanying vertebral compression fractures (VCFs) is a primary driver of the balloon kyphoplasty device industry. Osteoporosis affects about 10% of the world's population, with the incidence increasing considerably among people over the age of 50. In the United States alone, approximately 10 million people have osteoporosis, and another 44 million have low bone mass, putting them at a higher risk of getting the disorder. VCFs are a common osteoporosis consequence, with an estimated 1.5 million occurrences reported annually worldwide.
The aging global population adds to this trend, as the risk of osteoporosis and related fractures rises with age. These factors combine to boost demand for successful treatment alternatives such as balloon kyphoplasty, resulting in market expansion and innovation in device development.
Market Restraint: Reimbursement challenges and high procedural costs
The balloon kyphoplasty devices industry faces severe constraints due to reimbursement issues and high procedural costs. Many locations still have limited or inconsistent insurance coverage for kyphoplasty operations, forcing patients to pay out of cash.
The average cost of a balloon kyphoplasty treatment ranges between $8,000 and $15,000, which may be prohibitively expensive for certain patients who lack proper insurance coverage. This expensive burden may dissuade individuals from obtaining treatment, limiting market expansion.
Segment Overview:
The balloon catheters segment is expected to dominate the market throughout the forecast period.
Balloon catheters are essential in the kyphoplasty operation because they make it easier to create a space within the vertebral body for cement injection. The dominance of this market can be due to constant technological breakthroughs in catheter design, which improve the procedure's precision and efficacy. For example, the development of multi-lumen catheters has improved control and reduced procedure time, leading to increased acceptance among surgeons.
Recent advances in balloon catheter technology have centred on increasing the strength and longevity of the materials utilised, allowing for higher inflation pressures and more effective fracture reduction. Companies such as Medtronic and Stryker have created new balloon catheter systems with enhanced navigational capabilities, accelerating the segment's growth.
The balloon catheter market has also profited from the rising occurrence of osteoporotic fractures. According to recent figures, roughly 1.5 million spinal fractures occur each year around the world, with a sizable proportion of them suited for balloon kyphoplasty. This high incidence rate, combined with the increased acceptance of minimally invasive spine operations, fuels the market need for specialised balloon catheters.
Regional Outlook:
North America is expected to dominate the balloon kyphoplasty devices market during the forecast period.
Several factors contribute to North America's dominance in the balloon kyphoplasty device industry, including a high prevalence of osteoporosis, well-established healthcare infrastructure, and favourable reimbursement regulations. The region has seen a considerable growth in the elderly population, which is more vulnerable to spinal compression fractures. According to our estimates, around 10 million Americans have osteoporosis, while another 44 million have poor bone mass, increasing their risk of fractures.
In the North American market, leading competitors such as Medtronic and Stryker have recently introduced sophisticated kyphoplasty systems. These firms have concentrated on improving the precision and efficacy of their devices, resulting in market growth in the region.
Key figures demonstrate the market potential in North America. For example, in the United States, over 700,000 spinal compression fractures occur each year, with roughly 25% of these cases treated with kyphoplasty or vertebroplasty. This high incidence rate, combined with rising awareness and adoption of minimally invasive methods, drives market expansion in the region.
In terms of country-specific changes, balloon kyphoplasty treatments are becoming more popular in Canada, owing to measures aimed at improving access to modern spinal care. The Canadian Spine Society has actively promoted education and training in minimally invasive spine surgeries, such as kyphoplasty, which has helped to expand the country's market.
Competitive Intelligence:
The balloon kyphoplasty devices market is characterised by fierce rivalry among leading competitors, with an emphasis on technological innovation and strategic alliances. Leading firms, such as Medtronic, Stryker, and Merit Medical Systems, have considerable market shares thanks to their established distribution networks and diverse product portfolios. These firms have made significant investments in R&D to create innovative kyphoplasty systems with higher safety profiles and better clinical results.
Recent market trends show an increasing emphasis on the development of biodegradable cement materials and navigation-assisted kyphoplasty systems. Medtronic's Kyphon™ Balloon Kyphoplasty technology is recognised for its precise and successful treatment of spinal compression fractures. The company's spine segment revenue has steadily increased, with kyphoplasty devices playing a crucial role in this expansion.
Mergers and acquisitions have also played an important role in defining the competitive landscape. Stryker has bought Wright Medical Group N.V., boosting its foothold in the extremities and biologics markets while also complementing its spine portfolio. This strategic approach is intended to help Stryker increase its market presence and product options in the kyphoplasty category.
According to our research analysis that the market's top companies have maintained healthy profit margins, which typically range between 15% and 20%. However, increased competition from emerging firms, as well as the entry of local manufacturers into developing markets, are projected to have an impact on pricing tactics and market share in the coming years. The future forecast for the balloon kyphoplasty devices market is good, with chances for growth in emerging nations and the possibility of technical breakthroughs driving market expansion.
Analyst Opinion:
The market for balloon kyphoplasty devices is expected to increase significantly, owing to the rising prevalence of osteoporosis and spinal compression fracture. The move to minimally invasive procedures, as well as the expanding senior population, are important drivers of market growth.
The incorporation of augmented reality and navigation technology into kyphoplasty treatments has emerged as a unique market trend, enhancing precision and improving patient results.
Major Players:
-
Medtronic plc
-
Stryker Corporation
-
Merit Medical Systems, Inc.
-
DePuy Synthes (Johnson & Johnson)
-
Globus Medical, Inc.
-
Zimmer Biomet Holdings, Inc.
-
Becton, Dickinson and Company
-
Cook Medical LLC
-
Joline GmbH & Co. KG
-
SOMATEX Medical Technologies GmbH
Key Developments:
-
In June 2023, Medtronic got FDA approval for its next-generation balloon kyphoplasty system, which has improved navigation.
-
In April 2023, Stryker introduced an improved bone cement delivery method for kyphoplasty surgeries that improves cement viscosity control.
1. INTRODUCTION
1.1. Market Definitions & Study Assumptions
1.2. Market Research Scope and Segment
1.3. Research Methodology
2. EXECUTIVE SUMMARY
2.1. Market Overview & Insights
2.2. Segment Outlook
2.3. Region Outlook
3. COMPETITIVE INTELLIGENCE
3.1. Companies Financial Position
3.2. Company Benchmarking—Key Players
3.3. Market Share Analysis -- Key Companies
3.4. Recent Companies Key Activities
3.5. Pricing Analysis
3.6. SWOT Analysis
4. COMPANY PROFILES (Key Companies List by Country) (Premium)
5. COMPANY PROFILES
5.1. Medtronic plc
5.2. Stryker Corporation
5.3. Merit Medical Systems, Inc.
5.4. DePuy Synthes (Johnson & Johnson)
5.5. Globus Medical, Inc.
5.6. Zimmer Biomet Holdings, Inc.
5.7. Becton, Dickinson and Company
5.8. Cook Medical LLC
5.9. Joline GmbH & Co. KG
5.10. SOMATEX Medical Technologies GmbH (LIST NOT EXHAUSTIVE)
6. MARKET DYNAMICS
6.1. Market Trends
6.1.1. Shift towards outpatient procedures driving market growth
6.1.2. Integration of augmented reality in kyphoplasty procedures
6.1.3. Development of biodegradable cement materials
6.2. Market Drivers
6.2.1. Rising prevalence of osteoporosis and vertebral compression fractures
6.2.2. Increasing adoption of minimally invasive spine surgeries
6.2.3. Technological advancements in balloon kyphoplasty devices
6.3. Market Restraints
6.3.1. Reimbursement challenges and high procedural costs
6.3.2. Risk of complications associated with kyphoplasty procedures
6.4. Market Opportunities
6.5. Porter's Five Forces Analysis
6.5.1. Threat of New Entrants
6.5.2. Bargaining Power of Buyers/Consumers
6.5.3. Bargaining Power of Suppliers
6.5.4. Threat of Substitute Products
6.5.5. Intensity of Competitive Rivalry
6.6. Supply Chain Analysis
6.7. Value Chain Analysis
6.8. Trade Analysis
6.9. Pricing Analysis
6.10. Regulatory Analysis
6.11. Patent Analysis
6.12. SWOT Analysis
6.13. PESTLE Analysis
7. BY PRODUCT TYPE (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
7.1. Balloon Catheters
7.2. Bone cement
7.3. Needles
7.4. Inflatable Bone Tamps
8. BY APPLICATION (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH)--2020-2031)
8.1. Osteoporotic Fractures
8.2. Traumatic Fractures
8.3. Multiple Myeloma
9. BY END USER (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
9.1. Hospitals
9.2. Ambulatory Surgical Centres
9.3. Speciality Clinics
10. REGION (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
10.1. North America
10.1.1. United States
10.1.2. Canada
10.1.3. Mexico
10.2. South America
10.2.1. Brazil
10.2.2. Argentina
10.2.3. Rest of South America
10.3. Europe
10.3.1. Germany
10.3.2. United Kingdom
10.3.3. France
10.3.4. Italy
10.3.5. Spain
10.3.6. Russia
10.3.7. Rest of Europe
10.4. Asia-Pacific
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. Australia
10.4.5. South Korea
10.4.6. Rest of Asia-Pacific
10.5. Middle-East
10.5.1. UAE
10.5.2. Saudi Arabia
10.5.3. Turkey
10.5.4. Rest of Middle East
10.6. Africa
10.6.1. South Africa
10.6.2. Egypt
10.6.3. Rest of Africa
*NOTE: All the regions mentioned in the scope will be provided with (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (2020-2031)
By Product Type:
-
Balloon Catheters
-
Bone Cement
-
Needles
-
Inflatable Bone Tamps
By Application:
-
Osteoporotic Fractures
-
Traumatic Fractures
-
Multiple Myeloma
By End User:
-
Hospitals
-
Ambulatory Surgical Centres
-
Speciality Clinics
By Region:
-
North America
-
Europe
-
Asia-Pacific
-
Latin America
-
Middle East & Africa
Frequently Asked Questions
We at Aurorawave Intellects Market Report gives total market analysis that suit our customer business need and permit decision maker to run organizations without any problem. We have accomplished greatness in giving start to finish market research arrangements. Our detachment of industry specialists accumulate key data and get ready substance that lines up with our customer's business/specialty.
We at aurorawaveintellects.com offer mainly 3 types of licenses:
• Single User: Research Report copy can be distributed to a single user only
• Multi User: Research Report distribution is restricted up to 5 users.
• Corporate License :Research Report can be distributed across the company.
Based on the nature of the topic or research, the formats vary. The different formats of the report are as following:
• Word Document
• PPT
Following modes are available for making the payment:
• Online Payment (Visa Card, Master Card, Stripe)
• Razorpay
• Net Banking
• Bank Wire Transfer
Our customer service and research specialist team are available by phone and by email. Customer service hours are 24X7 Indian Standard Time (IST). You may reach us at:
• Email: info@aurorawaveintellects.com
• United Kingdom: ++91 7382742511